详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)

76| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

单位： [1]Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Oncol, 7 Chung Shan South Rd, Taipei 100, Taiwan [2]Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Med Imaging, Taipei, Taiwan [3]Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei, Taiwan [4]Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Surg, Taipei, Taiwan [5]Tokyo Univ Hosp, Dept Surg, Tokyo, Japan [6]Kinki Univ, Fac Med, Dept Radiol, Osaka, Japan [7]Chinese Univ Hong Kong, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China [8]Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea [9]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China [10]Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea [11]Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan

出处：

DOI：

ISSN：

关键词： Chemotherapy Hepatocellular carcinoma Imaging Surgery Radiotherapy

摘要：

A key mission of the Asia-Pacific Primary Liver Cancer Expert (APPLE) Association is to ensure a coherent view for management of hepatocellular carcinoma (HCC) and to advance new treatment for this difficult disease. At the 5th APPLE meeting, held in July 2014 in Taipei, Taiwan, an APPLE consensus development program was established to facilitate discussion among experts in the Asia-Pacific region on pertinent issues for HCC management, including (1) surgery for intermediate/advanced-stage disease, (2) prevention of HCC recurrence after curative treatment, (3) optimizing imaging diagnosis, (4) radiotherapy: current practice and future clinical trials, and (5) the role of cytotoxic chemotherapy. A pre-congress questionnaire was undertaken with the consensus development committee members to help understand the current practice patterns for HCC in the Asia-Pacific region and to identify issues relating to optimal patient care and further clinical trials for which consensus needs to be developed. In this report, the results of the questionnaire are presented, and the pertinent issues identified by each consensus group for further discussion and consensus development are summarized. Copyright (C) 2015 S. Karger AG, Basel

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2014]版：

无

最新[2025]版：

大类 | 1 区

医学

小类 | 2 区胃肠肝病学 2 区肿瘤学

JCR分区：

出版当年[2013]版：

无

最新[2023]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY Q1 ONCOLOGY

影响因子： 最新[2023版] 11.6 最新五年平均[2021-2025] 12.3 出版当年[2013版] 0 出版当年五年平均[2009-2013] 0 出版前一年[2012版] 0

第一作者：

第一作者单位： [1]Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Oncol, 7 Chung Shan South Rd, Taipei 100, Taiwan [11]Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan

通讯作者：

通讯机构： [1]Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Oncol, 7 Chung Shan South Rd, Taipei 100, Taiwan [11]Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Adjuvant radiotherapy in central hepatocellular carcinoma after narrow-margin hepatectomy: A 10-year real-world evidence [2]Predicting hepatocellular carcinoma early recurrence after ablation based on magnetic resonance imaging radiomics nomogram [3]小肝癌的影像学诊断进展 [4]Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017 [5]Early Response of Hepatocellular Carcinoma to Chemoembolization: Volume Computed Tomography Liver Perfusion Imaging as a Short-Term Response Predictor [6]Preoperative Radiotherapy Combined with Capecitabine Chemotherapy in Chinese Patients with Locally Advanced Rectal Cancer [7]Diagnostic accuracy of quantitative diffusion parameters in the pathological grading of hepatocellular carcinoma: A meta-analysis [8]肝动脉化疗栓塞结合外放射治疗大肝癌的预后因素分析 [9]肝细胞癌的治疗 [10]Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma A SQUIRE-compliant study